GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) » Definitions » Equity-to-Asset

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Equity-to-Asset : 0.81 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Laboratorio Farmaceutico Erfo SpA's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €7.55 Mil. Laboratorio Farmaceutico Erfo SpA's Total Assets for the quarter that ended in Dec. 2024 was €9.38 Mil. Therefore, Laboratorio Farmaceutico Erfo SpA's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.81.

The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset or its related term are showing as below:

MIL:ERFO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33   Med: 0.6   Max: 0.81
Current: 0.81

During the past 6 years, the highest Equity to Asset Ratio of Laboratorio Farmaceutico Erfo SpA was 0.81. The lowest was 0.33. And the median was 0.60.

MIL:ERFO's Equity-to-Asset is ranked better than
87.15% of 1930 companies
in the Consumer Packaged Goods industry
Industry Median: 0.55 vs MIL:ERFO: 0.81

Laboratorio Farmaceutico Erfo SpA Equity-to-Asset Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Equity-to-Asset Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial 0.80 0.68 0.33 0.37 0.81

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.77 0.37 0.76 0.81

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset falls into.


;
;

Laboratorio Farmaceutico Erfo SpA Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Laboratorio Farmaceutico Erfo SpA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=7.552/9.377
=0.81

Laboratorio Farmaceutico Erfo SpA's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=7.552/9.377
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Farmaceutico Erfo SpA  (MIL:ERFO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Laboratorio Farmaceutico Erfo SpA Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Farmaceutico Erfo SpA Business Description

Traded in Other Exchanges
N/A
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines